A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://link.springer.com/doi/10.1007/s00702-014-1315-y below:

Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies

  • Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 74:209–225

    Article  CAS  Google Scholar 

  • Alonso AD, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91:5562–5566

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Alonso AD, Grundke-Iqbal I, Iqbal K (1996) Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783–787

    Article  CAS  PubMed  Google Scholar 

  • Amadoro G, Serafino AL, Barbato C, Ciotti MT, Sacco A, Calissano P, Canu N (2004) Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cel Death Differ 11:217–230. doi:10.1038/sj.cdd.4401314

    Article  CAS  Google Scholar 

  • Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc Natl Acad Sci USA 103:2892–2897. doi:10.1073/pnas.0511065103

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631–639

    Article  CAS  PubMed  Google Scholar 

  • Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115–9129

    Article  CAS  PubMed  Google Scholar 

  • Avila J, Simon D, Diaz-Hernandez M, Pintor J, Hernandez F (2014) Sources of extracellular tau and its signaling. J Alzheimers Dis 40(Suppl 1):S7–S15. doi:10.3233/JAD-131832

    PubMed  Google Scholar 

  • Bensadoun A, Weinstein D (1976) Assay of proteins in the presence of interfering materials. Anal Biochem 70:241–250

    Article  CAS  PubMed  Google Scholar 

  • Bi M, Ittner A, Ke YD, Gotz J, Ittner LM (2011) Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One 6:e26860. doi:10.1371/journal.pone.0026860

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H (2010) Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Exp Neurol 224:472–485. doi:10.1016/j.expneurol.2010.05.010

    Article  CAS  PubMed  Google Scholar 

  • Boutajangout A, Quartermain D, Sigurdsson EM (2010) Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci 30:16559–16566. doi:10.1523/JNEUROSCI.4363-10.2010

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118:658–667. doi:10.1111/j.1471-4159.2011.07337.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351–357

    Article  CAS  PubMed  Google Scholar 

  • Braak H, Zetterberg H, Del Tredici K, Blennow K (2013) Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-beta changes occur before increases of tau in cerebrospinal fluid. Acta Neuropathol 126:631–641. doi:10.1007/s00401-013-1139-0

    Article  CAS  PubMed  Google Scholar 

  • Castillo-Carranza DL et al (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260–4272. doi:10.1523/JNEUROSCI.3192-13.2014

    Article  PubMed  Google Scholar 

  • Chai X et al (2011) Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. J Biol Chem 286:34457–34467. doi:10.1074/jbc.M111.229633

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Clavaguera F et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Clavaguera F et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535–9540. doi:10.1073/pnas.1301175110

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Clinton LK et al (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 28:76–82

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Corsetti V et al (2008) Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer’s disease models. Mol Cell Neurosci 38:381–392. doi:10.1016/j.mcn.2008.03.011

    Article  CAS  PubMed  Google Scholar 

  • d’Abramo C, Acker CM, Jimenez HT, Davies P (2013) Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One 8:e62402. doi:10.1371/journal.pone.0062402

    Article  PubMed Central  PubMed  Google Scholar 

  • Denk F, Wade-Martins R (2009) Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging 30:1–13. doi:10.1016/j.neurobiolaging.2007.05.010

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • D’Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60–90

    Article  PubMed  Google Scholar 

  • Doody RS et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med 370:311–321. doi:10.1056/NEJMoa1312889

    Article  CAS  PubMed  Google Scholar 

  • Flight MH (2013) Neurodegenerative disease: tau immunotherapy targets transcellular propagation. Nat Rev Drug Discov 12:904. doi:10.1038/nrd4179

    Article  CAS  PubMed  Google Scholar 

  • Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845–12852. doi:10.1074/jbc.M808759200

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Garg S, Timm T, Mandelkow EM, Mandelkow E, Wang Y (2011) Cleavage of Tau by calpain in Alzheimer’s disease: the quest for the toxic 17 kD fragment. Neurobiol Aging 32:1–14. doi:10.1016/j.neurobiolaging.2010.09.008

    Article  CAS  PubMed  Google Scholar 

  • Giacobini E, Gold G (2013) Alzheimer disease therapy-moving from amyloid-beta to tau. Nat Rev Neurol. doi:10.1038/nrneurol.2013.223

    PubMed  Google Scholar 

  • Giannakopoulos P et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60:1495–1500

    Article  CAS  PubMed  Google Scholar 

  • Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890

    Article  CAS  PubMed  Google Scholar 

  • Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913–4917

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gu J, Congdon EE, Sigurdsson EM (2013) Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology. J Biol Chem 288:33081–33095. doi:10.1074/jbc.M113.494922

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Holmes C et al (2008) Long-term effects of Abeta42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216–223

    Article  CAS  PubMed  Google Scholar 

  • Iqbal K et al (1986) Defective brain microtubule assembly in Alzheimer’s disease. Lancet 2:421–426

    Article  CAS  PubMed  Google Scholar 

  • Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K (2014) Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer’s disease. Neurobiol Dis. doi:10.1016/j.nbd.2014.07.001

    PubMed  Google Scholar 

  • Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374–24384

    CAS  PubMed  Google Scholar 

  • Lambracht-Washington D, Rosenberg RN (2013) Anti-amyloid beta to tau-based immunization: developments in immunotherapy for Alzheimer disease. Immuno Targets Ther 2013:105–114. doi:10.2147/ITT.S31428

    Article  Google Scholar 

  • Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, Trinczek B, Mandelkow E (1996) Structure, microtubule interactions, and phosphorylation of tau protein. Ann N Y Acad Sci 777:96–106

    Article  CAS  PubMed  Google Scholar 

  • Masliah E et al (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson’s disease. Neuron 46:857–868. doi:10.1016/j.neuron.2005.05.010

    Article  CAS  PubMed  Google Scholar 

  • Morris RG, Garrud P, Rawlins JN, O’Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681–683

    Article  CAS  PubMed  Google Scholar 

  • Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003a) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiol Aging 24:1063–1070

    Article  CAS  PubMed  Google Scholar 

  • Oddo S et al (2003b) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409–421

    Article  CAS  PubMed  Google Scholar 

  • Park SY, Ferreira A (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25:5365–5375. doi:10.1523/JNEUROSCI.1125-05.2005

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Reinecke JB et al (2011) Implicating calpain in tau-mediated toxicity in vivo. PloS One 6:e23865. doi:10.1371/journal.pone.0023865

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Reitz C (2012) Alzheimer’s disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis 2012:369808. doi:10.1155/2012/369808

    PubMed Central  PubMed  Google Scholar 

  • Roberson ED et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model. Science 316:750–754

    Article  CAS  PubMed  Google Scholar 

  • Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ (2006) Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer’s disease. J Neurosci 26:13384–13389. doi:10.1523/JNEUROSCI.2514-06.2006

    Article  CAS  PubMed  Google Scholar 

  • Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, Abramsky O (2006) Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 63:1459–1467. doi:10.1001/archneur.63.10.1459

    Article  PubMed  Google Scholar 

  • Salloway S et al (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med 370:322–333. doi:10.1056/NEJMoa1304839

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sanders DW et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271–1288. doi:10.1016/j.neuron.2014.04.047

    Article  CAS  PubMed  Google Scholar 

  • Sigurdsson EM (2008) Immunotherapy targeting pathological tau protein in Alzheimer’s disease and related tauopathies. J Alzheimers Dis 15:157–168

    PubMed Central  CAS  PubMed  Google Scholar 

  • Terry RD et al (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580

    Article  CAS  PubMed  Google Scholar 

  • Thies W, Bleiler L, Alzheimer’s A (2013) 2013 Alzheimer’s disease facts and figures. Alzheimers Dement 9:208–245. doi:10.1016/j.jalz.2013.02.003

    Article  Google Scholar 

  • Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11:205–242

    Article  CAS  PubMed  Google Scholar 

  • Troquier L et al (2012) Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res 9:397–405

    Article  PubMed Central  PubMed  Google Scholar 

  • Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer’s disease. Acta Neuropathol 83:170–178

    Article  CAS  PubMed  Google Scholar 

  • Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848–858. doi:10.1038/nprot.2006.116

    Article  PubMed Central  PubMed  Google Scholar 

  • Winblad B, Graf A, Riviere ME, Andreasen N, Ryan JM (2014) Active immunotherapy options for Alzheimer’s disease. Alzheimers Res Ther 6:7. doi:10.1186/alzrt237

    Article  PubMed Central  PubMed  Google Scholar 

  • Yanamandra K et al (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402–414. doi:10.1016/j.neuron.2013.07.046

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zilka N, Kontsekova E, Novak M (2008) Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies. J Alzheimers Dis 15:169–179

    CAS  PubMed  Google Scholar 


  • RetroSearch is an open source project built by @garambo | Open a GitHub Issue

    Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

    HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4